Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy.
Département de Maladies Infectieuses et de Médecine Tropicale, H pital de la Pitié-Salpêtrière, Paris, France.
L
L
Baril
I
I
Beucler
M A
MA
Valantin
E
E
Bruckert
D
D
Bonnefont-Rousselot
A
A
Coutellier
E
E
Caumes
C
C
Katlama
F
F
Bricaire
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000097:blood; D002784:Cholesterol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006493:Heparin; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced* / Q000201:enzymology; D008049:Lipase / Q000097:blood*; D008071:Lipoprotein Lipase / Q000097:blood*; D008297:Male; D014280:Triglycerides / Q000097:blood
D053304:Apolipoprotein C-II; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol; D008049:Lipase; D008071:Lipoprotein Lipase